Ladenburg Thalmann Financial Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $198K | Sell |
1,834
-113
| -6% | -$12.2K | ﹤0.01% | 2511 |
|
|
2019
Q3 | $175K | Sell |
1,947
-337
| -15% | -$30.3K | ﹤0.01% | 2566 |
|
|
2019
Q2 | $193K | Sell |
2,284
-147
| -6% | -$12.4K | ﹤0.01% | 2497 |
|
|
2019
Q1 | $214K | Sell |
2,431
-174
| -7% | -$15.3K | ﹤0.01% | 2345 |
|
|
2018
Q4 | $186K | Buy |
2,605
+17
| +0.7% | +$1.21K | ﹤0.01% | 2288 |
|
|
2018
Q3 | $319K | Buy |
2,588
+572
| +28% | +$70.5K | ﹤0.01% | 1943 |
|
|
2018
Q2 | $167K | Hold |
2,016
| – | – | ﹤0.01% | 2373 |
|
|
2018
Q1 | $167K | Buy |
2,016
+1,025
| +103% | +$84.9K | ﹤0.01% | 2373 |
|
|
2017
Q4 | $77K | Sell |
991
-3,188
| -76% | -$248K | ﹤0.01% | 2911 |
|
|
2017
Q3 | $256K | Buy |
4,179
+122
| +3% | +$7.47K | ﹤0.01% | 1914 |
|
|
2017
Q2 | $187K | Hold |
4,057
| – | – | ﹤0.01% | 2075 |
|
|
2017
Q1 | $176K | Buy |
4,057
+3,290
| +429% | +$143K | ﹤0.01% | 2005 |
|
|
2016
Q4 | $31K | Sell |
767
-1,010
| -57% | -$40.8K | ﹤0.01% | 3186 |
|
|
2016
Q3 | $90K | Buy |
1,777
+56
| +3% | +$2.84K | ﹤0.01% | 2325 |
|
|
2016
Q2 | $78K | Sell |
1,721
-55
| -3% | -$2.49K | ﹤0.01% | 2338 |
|
|
2016
Q1 | $71K | Sell |
1,776
-38
| -2% | -$1.52K | ﹤0.01% | 2326 |
|
|
2015
Q4 | $103K | Sell |
1,814
-30
| -2% | -$1.7K | ﹤0.01% | 2038 |
|
|
2015
Q3 | $73K | Buy |
1,844
+1,449
| +367% | +$57.4K | ﹤0.01% | 2211 |
|
|
2015
Q2 | $19K | Hold |
395
| – | – | ﹤0.01% | 3270 |
|
|
2015
Q1 | $15K | Buy |
395
+35
| +10% | +$1.33K | ﹤0.01% | 3369 |
|
|
2014
Q4 | $8K | Buy |
360
+300
| +500% | +$6.67K | ﹤0.01% | 3526 |
|
|
2014
Q3 | $1K | Hold |
60
| – | – | ﹤0.01% | 3809 |
|
|
2014
Q2 | $1K | Sell |
60
-740
| -93% | -$12.3K | ﹤0.01% | 3771 |
|
|
2014
Q1 | $13K | Buy |
800
+300
| +60% | +$4.88K | ﹤0.01% | 2816 |
|
|
2013
Q4 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 3257 |
|
|
2013
Q3 | – | Sell |
-400
| Closed | -$5K | – | 3776 |
|
|
2013
Q2 | $5K | Buy |
+400
| New | +$5K | ﹤0.01% | 3047 |
|